Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia.

Vyas NS, Buchsbaum MS, Lehrer DS, Merrill BM, DeCastro A, Doninger NA, Christian BT, Mukherjee J.

Schizophr Res. 2018 Feb;192:442-456. doi: 10.1016/j.schres.2017.05.017. Epub 2017 May 31.

PMID:
28576546
2.

D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia.

Buchsbaum MS, Christian BT, Lehrer DS, Narayanan TK, Shi B, Mantil J, Kemether E, Oakes TR, Mukherjee J.

Schizophr Res. 2006 Jul;85(1-3):232-44. Epub 2006 May 19.

PMID:
16713185
3.

Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).

Vernaleken I, Fellows C, Janouschek H, Bröcheler A, Veselinovic T, Landvogt C, Boy C, Buchholz HG, Spreckelmeyer K, Bartenstein P, Cumming P, Hiemke C, Rösch F, Schäfer W, Wong DF, Gründer G.

J Clin Psychopharmacol. 2008 Dec;28(6):608-17. doi: 10.1097/JCP.0b013e31818ba2f6.

PMID:
19011428
4.

The role of striatal dopamine D2/3 receptors in cognitive performance in drug-free patients with schizophrenia.

Veselinović T, Vernaleken I, Janouschek H, Cumming P, Paulzen M, Mottaghy FM, Gründer G.

Psychopharmacology (Berl). 2018 Aug;235(8):2221-2232. doi: 10.1007/s00213-018-4916-6. Epub 2018 May 1.

PMID:
29717334
5.

The relationship between excitement symptom severity and extrastriatal dopamine D2/3 receptor availability in patients with schizophrenia: a high-resolution PET study with [18F]fallypride.

Joo YH, Kim JH, Son YD, Kim HK, Shin YJ, Lee SY, Kim JH.

Eur Arch Psychiatry Clin Neurosci. 2018 Sep;268(6):529-540. doi: 10.1007/s00406-017-0821-y. Epub 2017 Jun 16.

PMID:
28623450
6.

Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users.

Ballard ME, Dean AC, Mandelkern MA, London ED.

PLoS One. 2015 Dec 14;10(12):e0143510. doi: 10.1371/journal.pone.0143510. eCollection 2015.

7.

Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task.

Suridjan I, Rusjan P, Addington J, Wilson AA, Houle S, Mizrahi R.

J Psychiatry Neurosci. 2013 Mar;38(2):98-106. doi: 10.1503/jpn.110181.

8.

Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study.

Woodward ND, Zald DH, Ding Z, Riccardi P, Ansari MS, Baldwin RM, Cowan RL, Li R, Kessler RM.

Neuroimage. 2009 May 15;46(1):31-8. doi: 10.1016/j.neuroimage.2009.01.049. Epub 2009 Feb 5. Erratum in: Neuroimage. 2009 Oct 1;47(4):2090.

9.

Striatal and extrastriatal dopamine D2/D3 receptors in schizophrenia evaluated with [18F]fallypride positron emission tomography.

Kegeles LS, Slifstein M, Xu X, Urban N, Thompson JL, Moadel T, Harkavy-Friedman JM, Gil R, Laruelle M, Abi-Dargham A.

Biol Psychiatry. 2010 Oct 1;68(7):634-41. doi: 10.1016/j.biopsych.2010.05.027. Epub 2010 Jul 31.

10.

The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.

Gründer G, Landvogt C, Vernaleken I, Buchholz HG, Ondracek J, Siessmeier T, Härtter S, Schreckenberger M, Stoeter P, Hiemke C, Rösch F, Wong DF, Bartenstein P.

Neuropsychopharmacology. 2006 May;31(5):1027-35.

11.

Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [(18)F]fallypride.

Ota M, Ogawa S, Kato K, Masuda C, Kunugi H.

Neurosci Res. 2015 Dec;101:1-5. doi: 10.1016/j.neures.2015.07.008. Epub 2015 Jul 29.

PMID:
26232153
12.

Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNO.

Girgis RR, Slifstein M, D'Souza D, Lee Y, Periclou A, Ghahramani P, Laszlovszky I, Durgam S, Adham N, Nabulsi N, Huang Y, Carson RE, Kiss B, Kapás M, Abi-Dargham A, Rakhit A.

Psychopharmacology (Berl). 2016 Oct;233(19-20):3503-12. doi: 10.1007/s00213-016-4382-y. Epub 2016 Aug 15.

13.

Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.

Nørbak-Emig H, Ebdrup BH, Fagerlund B, Svarer C, Rasmussen H, Friberg L, Allerup PN, Rostrup E, Pinborg LH, Glenthøj BY.

Int J Neuropsychopharmacol. 2016 Apr 29;19(5). pii: pyw006. doi: 10.1093/ijnp/pyw006. Print 2016 May.

14.

Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride.

Kaur J, Khararjian A, Coleman RA, Constantinescu CC, Pan ML, Mukherjee J.

Nucl Med Biol. 2014 Nov-Dec;41(10):841-7. doi: 10.1016/j.nucmedbio.2014.08.002. Epub 2014 Aug 8.

15.

Reduced D2/D3 Receptor Binding of Extrastriatal and Striatal Regions in Temporal Lobe Epilepsy.

Bernedo Paredes VE, Buchholz HG, Gartenschläger M, Breimhorst M, Schreckenberger M, Werhahn KJ.

PLoS One. 2015 Nov 6;10(11):e0141098. doi: 10.1371/journal.pone.0141098. eCollection 2015.

16.
17.

Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D2 /D3 dopamine system.

Pfeifer P, Tüscher O, Buchholz HG, Gründer G, Vernaleken I, Paulzen M, Zimmermann US, Maus S, Lieb K, Eggermann T, Fehr C, Schreckenberger M.

Addict Biol. 2017 Sep;22(5):1449-1458. doi: 10.1111/adb.12424. Epub 2016 Jul 11.

PMID:
27396374
18.

Posterior dopamine D2/3 receptors and brain network functional connectivity.

Nagano-Saito A, Lissemore JI, Gravel P, Leyton M, Carbonell F, Benkelfat C.

Synapse. 2017 Nov;71(11). doi: 10.1002/syn.21993. Epub 2017 Aug 7.

PMID:
28700819
19.

Relationship of frontal D(2/3) binding potentials to cognition: a study of antipsychotic-naive schizophrenia patients.

Fagerlund B, Pinborg LH, Mortensen EL, Friberg L, Baaré WF, Gade A, Svarer C, Glenthøj BY.

Int J Neuropsychopharmacol. 2013 Feb;16(1):23-36. doi: 10.1017/S146114571200003X. Epub 2012 Feb 17.

PMID:
22338593
20.

Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.

Werhahn KJ, Landvogt C, Klimpe S, Buchholz HG, Yakushev I, Siessmeier T, Müller-Forell W, Piel M, Rösch F, Glaser M, Schreckenberger M, Bartenstein P.

Epilepsia. 2006 Aug;47(8):1392-6.

Supplemental Content

Support Center